Core Scientific, Inc.
CORZQ News Today: Stay Updated with the Latest Core Scientific, Inc. News in Real Time
Find CORZQ news now at Meyka AI. Stay informed with the latest Core Scientific, Inc. stocks updates, including price news, market analysis, and expert insights.
SABTN.BO INR 378.00 pre-market (Sri Adhikari TV, BSE): high-volume setup
Pre-market high-volume alert for SABTN.BO stock at INR 378.00 on 26 Mar 2026; volume surge and Meyka AI forecast for volatile trading
March 26: Tsubohachi Operator Begins Bankruptcy, JPY 600m Debt
Tsubohachi bankruptcy: Sapporo operator Shiratori Shoten begins bankruptcy with JPY 600 million liabilities. What it means for Japan’s izakaya sector, landlords, suppliers, and investors.
Maintained to Buy for SW Smurfit Westrock Plc by Cowen & Co March 2026
Cowen & Co maintained Buy on Smurfit Westrock Plc; SW analyst rating reviewed March 2026
Jefferies Maintains Buy on CytomX Therapeutics, Inc. (CTMX) $16 PT Mar 2026
CTMX analyst rating: Jefferies maintains Buy and raises PT to $16. Read implications and Meyka AI grade B+
Leerink Maintains Outperform for BTSG BrightSpring Health Services Mar 2026
Leerink maintains Outperform on BTSG. BTSG analyst rating update, market cap, and 1.02% price move explained
NASA Pivot March 25: Gateway Paused, Canada’s MDA Stock Slides
MDA stock slid after NASA paused the Gateway to prioritize a lunar surface base. We explain what this means for Canada, Canadarm3, and near-term catalysts for investors.
NGD.TO New Gold Inc. TSX up 3.31% to C$12.16 March 25 2026: most active stock with C$15.00 upside
NGD.TO stock trades C$12.16 on March 25 2026; Meyka AI flags C$15.00 near-term target for NGD.TO stock
Morgan Stanley Maintains Overweight on Autodesk (ADSK) Mar 2026
Morgan Stanley maintains Overweight; ADSK analyst rating stays unchanged in Mar 2026
Macquarie Maintains Outperform on GDS Holdings (GDS) March 2026
Macquarie and Morgan Stanley maintain bullish calls in March 2026; read the GDS analyst rating update and price target details